A detailed history of Clear Point Advisors Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Clear Point Advisors Inc. holds 507 shares of PFE stock, worth $13,496. This represents 0.01% of its overall portfolio holdings.

Number of Shares
507
Previous 504 0.6%
Holding current value
$13,496
Previous $14.1 Million 4.07%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$27.7 - $31.39 $83 - $94
3 Added 0.6%
507 $14.7 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $75 - $88
3 Added 0.6%
504 $14.1 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $103 - $118
4 Added 0.8%
501 $13.9 Million
Q4 2023

May 15, 2024

BUY
$26.13 - $33.94 $12,986 - $16,868
497 New
497 $14.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Clear Point Advisors Inc. Portfolio

Follow Clear Point Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Point Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clear Point Advisors Inc. with notifications on news.